Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018-2022).

Matteo BoattiniGabriele BiancoPaulo BastosSara CominiSilvia CorcioneAndré AlmeidaCristina CostaFrancesco Giuseppe De RosaRossana Cavallo

Published in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)

Ceftazidime/avibactam resistance in KPC-Kp BSI easily emerged in our highly KPC-Kp endemic area with remarkable mortality rates. Our findings might provide physicians possibly actionable information when managing patients with a ceftazidime/avibactam-resistant KPC-Kp BSI.

Keyphrases

klebsiella pneumoniae
multidrug resistant
gram negative
escherichia coli
risk factors
cardiovascular events
primary care
healthcare
coronary artery disease
type diabetes
health information